Company Overview and News

 
Sterlite Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates

15h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SRLRY 532374 STRTECH

 
Mid and small cap: Tech, pharma, consumer stocks top performers while majority of stocks trade in red

2018-10-17 financialexpress
While 90% of Nifty small-cap and 77% of Nifty mid-cap stocks have been trading in the red since the beginning of the year, some stocks from export-driven and consumer sector have given returns up to 89.26% in the small and mid cap space. However, this calender year, Nifty Midcap 100 and Nifty Small Cap 100 index has yielded a negative returns of 20.6% and 33.2% respectively.
500408 IDBLZ 532960 532541 MS 500031 500252 509488 NIITTECH GRAPHITE IBVENTURES HEXAWARE STRTECH 532129 LAXMIMACH SRLRY 532374 TATAELXSI BAJAJELEC

5
Sensex could top 44,000 after general elections; 7 buy ideas could return 20-90%

2018-10-16 moneycontrol
The Sensex is poised to touch 36,000-36,500 in the near-term and eventually go up to 44,000 after general elections 2019, Nalin Shah, Director at NVS Brokerage said in an interview to Moneycontrol's Sunil Shankar Matkar.
TVSMOTOR KMBKY JTEKY 532978 STRTECH SRLRY JTEKF 532343 BAJAJFINSV BAJFINANCE 532374 HDB LICHSGFIN 500180 KOTAKBANK HDFCBANK BJJQY LHFLY 500247 500570 TATAMOTORS 500253 500034 TTM

 
Sterlite Technologies climbs 4% on long term contract from Indian Navy

2018-10-16 moneycontrol
Sterlite Technologies share price gained more than 4 percent intraday after the company received purchase order for designing, building and managing the Indian Navy's digital network.
SRLRY 532374 STRTECH

 
Sterlite Technologies Limited - Press Release

2018-10-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SRLRY 532374 STRTECH

 
Sterlite Power commissions ₹3,000 cr project in Jammu and Kashmir

2018-10-15 thehindubusinessline
Sterlite Power, one of India’s largest power transmission sector players, has announced commissioning of the 414 km long Northern Region Strengthening Scheme 29 (NRSS 29), its flagship project critical for meeting the power requirements of the state of Jammu & Kashmir.
SRLRY 532374 NG NGGTF STRTECH NGG

 
Sterlite Power commissions ₹3,000 crore project in Jammu and Kashmir

2018-10-15 thehindubusinessline
Sterlite Power, one of India’s largest power transmission sector players, has announced commissioning of the 414 km long Northern Region Strengthening Scheme 29 (NRSS 29), its flagship project critical for meeting the power requirements of the state of Jammu & Kashmir.
SRLRY 532374 NG NGGTF STRTECH NGG

 
Sterlite Technologies Limited - Allotment of ESOP/ESPS

2018-09-24 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SRLRY 532374 STRTECH

 
Sterlite Technologies Limited - News Clarification

2018-09-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SRLRY 532374 STRTECH

 
5 parties bidding for 74% Malaysian Maxis owned Indian Aircel assets

2018-09-20 thestar.com.my
Aircel, which is 74% owned by Maxis Communications Bhd, reportedly owes about 50,000 crores to its creditors. Aircel is among the casualties of the intense competition in the Indian telecom market.
SRLRY 532454 RCOM 532374 PNJZY 532461 PNB STRTECH 532712 BHRQY BHARTIARTL SBAZ

 
Airtel, Sterlite Tech, two investment firms in race to buy Aircel assets

2018-09-20 moneycontrol
The assets of the beleaguered telecom company Aircel are up for sale and Bharti Airtel, Sterlite Technologies, among others and two investment firms are reportedly keen to separately buy them. Despite the number of interested buyers, the lenders to Aircel may still have to take a large haircut, according to Livemint.
SRLRY 532454 532374 PNJZY 532461 PNB STRTECH BHRQY BHARTIARTL SBAZ

 
Deals Buzz: ShareChat raises Rs 720 crore, valuation jumps seven-fold

2018-09-20 livemint
Deals Buzz brings to you, your dose of the top deals news reported from newsrooms across the country.
SRLRY 532454 532374 STRTECH BHRQY BHARTIARTL

 
Ananda Krishnan’s Aircel assets: Airtel, Jio are said to be among bidders

2018-09-20 theedgemarkets
SYDNEY (Sept 20): Bharti Airtel, Reliance Jio, Sterlite Technologies and two investment firms have bid to separately purchase assets of Aircel, the company linked to Malaysian tycoon T. Ananda Krishnan, Mint reports, citing two unidentified people with knowledge on the matter.
SRLRY 532454 532374 STRTECH BHRQY BHARTIARTL

 
Airtel, Jio, Sterlite Tech among bidders for Aircel assets

2018-09-20 livemint
Mumbai/New Delhi: Bharti Airtel Ltd, Reliance Jio Infocomm Ltd, Sterlite Technologies Ltd and two investment firms have bid to separately purchase assets of Aircel Ltd, but lenders to the bankrupt telecom operator may still have to take a large haircut. Lenders to Aircel are, however, keen on a lump sum sale to a single party as it believes such a move would lead to the best outcome, two people with knowledge of the matter said.
STRTECH BHRQY 532712 532775 GTLINFRA SRLRY 532454 PNJZY RCOM 532374 532461 PNB BHARTIARTL SBAZ

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...